A novel, error-corrected technique for identifying cancer from blood samples is significantly more sensitive and accurate than previous methods and could be helpful for monitoring patients' disease status following treatment, according to a study by Weill Cornell Medicine and New York Genome
A new method can illuminate the identities and activities of cells throughout an organ or a tumour at unprecedented resolution, according to a study co-led by researchers at Weill Cornell Medicine, NewYork-Presbyterian and the New York Genome Center.
The method, described in the study published journal 'Nature Biotechnology,' records gene activity patterns and the presence of key proteins in cells across tissue samples while retaining information about the cells' precise location. This allows for the creation of complex, data-rich "maps"
New York [US], September 22 (ANI): According to a study co-led by researchers at Weill Cornell Medicine, NewYork-Presbyterian, the New York Genome Center, Harvard Medical School, and Dana-Farber Cancer Institute, a typical, spontaneous mutation in blood stem cells, which has been linked to h